Wall Street Journal -- U.K.-based drugmaker GlaxoSmithKline PLC (GSK) Tuesday said governments around the world have so far ordered 440 million doses of its pandemic swine flu vaccine Pandemrix as they brace for a possible resurgence of the illness.
Wall Street Journal -- U.K.-based drugmaker GlaxoSmithKline PLC (GSK) Tuesday said governments around the world have so far ordered 440 million doses of its pandemic swine flu vaccine Pandemrix as they brace for a possible resurgence of the illness.
